Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$716K Buy
22,237
+6,070
+38% +$249K ﹤0.01% 1489
2025
Q4
$664K Buy
16,167
+3,767
+30% +$141K ﹤0.01% 1464
2025
Q3
$451K Sell
12,400
-1,277
-9% -$38.6K ﹤0.01% 1518
2025
Q2
$732K Buy
13,677
+1,623
+13% +$95.2K 0.01% 1143
2025
Q1
$725K Buy
12,054
+7,492
+164% +$453K 0.01% 961
2024
Q4
$311K Sell
4,562
-470
-9% -$29.3K ﹤0.01% 1318
2024
Q3
$374K Buy
5,032
+1,940
+63% +$142K 0.01% 1000
2024
Q2
$205K Buy
+3,092
New +$225K 0.01% 844

Other funds holding CNC

&Partners's CNC Position: Q1 2026 in Review

&Partners increased its Centene (CNC) stake by 38% in Q1 2026, buying an estimated $249K and bringing the position to 22,237 shares worth $716K. The position accounts for ﹤0.01% of the portfolio, ranked #1489.

&Partners first reported a position in CNC in Q2 2024 and has held it in 8 quarters since. The position peaked at $732K in Q2 2025. 862 funds tracked by Wall St. Rank hold CNC as of Q1 2026.

  • &Partners held 22,237 shares of Centene worth $716K as of Q1 2026.
  • &Partners bought 6,070 Centene shares in Q1 2026, an estimated $249K.
  • Centene made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1489 holding.
  • &Partners first reported a position in Centene in Q2 2024 and has held it in 8 quarters since.
  • &Partners's Centene position peaked at $732K in Q2 2025.
  • 862 funds tracked by Wall St. Rank held Centene as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.